Table 1. Treatment options for various forms cutaneous leishmaniasis [2, 6, 28, 39, 40, 41].
|
No. |
Categories |
Treatments |
|
1 |
Localized cutaneous leishmaniasis |
Weekly I/L Antimonial compounds |
|
2 |
Mucocutaneous leishmaniasis |
Weekly I/L Antimonial compounds Weekly I/M Pentamidine (in Africa)* Daily I/M Antimonial compounds (New World)* |
|
3 |
Diffuse cutaneous leishmaniasis |
Daily I/M Antimonial compounds* |
|
4 |
Leishmaniasis recidivans |
Weekly I/L Antimonial compounds Daily I/M Antimonial compounds |
|
5 |
Post kala-azar dermal leishmaniasis |
Daily I/M Antimonial compounds* |
|
6 |
Viscerotropic leishmaniasis |
Daily I/M Antimonial compounds* |
|
7 |
Atypical CL due to unusual sites. (Chancriform, Paronychial, Lid, Whitlow, Scalp, Scar) |
Weekly I/L Antimonial compounds Daily I/M Antimonial compounds |
|
8 |
Atypical CL due to unusual morphologies (Fissure, Erysipeloid, Lupoid, Annular, Psoriasiform, Eczematous, Keloidal, Palmoplanter) |
Weekly I/L Antimonial compounds Daily I/M Antimonial compounds (in selected cases when I/L treatment is unsatisfactory) |
|
9 |
Atypical CL due to unusual morphologies (Tumorous, DLE like, Verrucous, Rhinophymous, Acneiform Zosteriform, Sporotrichoid |
Daily I/M Antimonial compounds Weekly I/L Antimonial compounds (if lesions are smaller in size) |
|
10 |
Leishmaniasis in HIV positive patients |
Daily I/M Antimonial compounds |
I/L= intralesional, I/M= intramuscular, * not seen in Pakistan